Inhibition of mitogen-elicited signal transduction and growth in prostate cancer with a small peptide derived from the functional domain of DOC-2/DAB2 delivered by a unique vehicle

被引:25
作者
Zhou, Jian [1 ]
Fan, Jinhai [1 ]
Hsieh, Jer-Tsong [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Urol, Dallas, TX 75216 USA
关键词
D O I
10.1158/0008-5472.CAN-06-1726
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Differentially expressed in ovarian cancer-2/disabled 2 (DOC-2/DAB2) protein, often lost in prostate cancer and other cancer types, is a part of homeostatic machinery in normal prostate epithelium. DOC-2/DAB2 modulates mitogen-elicited mitogen-activated protein kinase (MAPK) signal transduction by sequestering several adaptor or effector molecules, such as growth factor receptor bound protein 2 and c-Src. We have shown that the proline-rich sequence in DOC-2/DAB2 is the key functional domain for this action. In this study, we further synthesized peptide based on the functional proline-rich domain and examined its biological function in prostate cancer using cell-permeable peptide (CPP) as a delivery system. From screening of several CPPs in prostate cancer cell lines, a polyarginine peptide (R11) seemed to be the best delivery vehicle because of its highly efficient uptake. In addition, we also observed a similar in vitro half-life and cellular location of R11 in four different prostate cancer cell lines. By conjugating a proline-rich sequence (PPL) or control sequence (AAL) derived from DOC-2/DAB2 to the COOH terminus of R11, we showed that R11PPL, but not R11 or R11AAL was able to suppress either serum- or androgen-induced cell proliferation in prostate cancer cells without endogenous DOC-2/DAB2 expression. Consistently, the activation status of NUM elicited by these mitogens was significantly inhibited by R11PPL but not by R11AAL or R11. Taken together, we conclude that a functional peptide derived from proline-rich domain in DOC-2/DAB2 has growth-inhibitory activity as its native protein, and CPP seems to be an efficient delivery system in prostate cancer cells.
引用
收藏
页码:8954 / 8958
页数:5
相关论文
共 19 条
[1]  
Datta K, 2001, CANCER RES, V61, P1768
[2]   A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides [J].
Fischer, R ;
Köhler, K ;
Fotin-Mleczek, M ;
Brock, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12625-12635
[3]   Oligoarginine vectors for intracellular delivery: Design and cellular-uptake mechanisms [J].
Futaki, S .
BIOPOLYMERS, 2006, 84 (03) :241-249
[4]   Arginine-rich peptides - An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery [J].
Futaki, S ;
Suzuki, T ;
Ohashi, W ;
Yagami, T ;
Tanaka, S ;
Ueda, K ;
Sugiura, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (08) :5836-5840
[5]  
Gioeli D, 1999, CANCER RES, V59, P279
[6]   Transducible peptide therapy for uveal melanoma and retinoblastoma [J].
Harbour, JW ;
Worley, L ;
Ma, DD ;
Cohen, M .
ARCHIVES OF OPHTHALMOLOGY, 2002, 120 (10) :1341-1346
[7]   Biological applications of protein transduction technology [J].
Kabouridis, PS .
TRENDS IN BIOTECHNOLOGY, 2003, 21 (11) :498-503
[8]  
Mayer BJ, 2001, J CELL SCI, V114, P1253
[9]   A new cell-permeable peptide allows successful allogeneic islet transplantation in mice [J].
Noguchi, H ;
Matsushita, M ;
Okitsu, T ;
Moriwaki, A ;
Tomizawa, K ;
Kang, SY ;
Li, ST ;
Kobayashi, N ;
Matsumoto, S ;
Tanaka, K ;
Tanaka, N ;
Matsui, H .
NATURE MEDICINE, 2004, 10 (03) :305-309
[10]   Activation of extracellular signal-regulated kinase in human prostate cancer [J].
Price, DT ;
Della Rocca, G ;
Guo, CH ;
Ballo, MS ;
Schwinn, DA ;
Luttrell, LM .
JOURNAL OF UROLOGY, 1999, 162 (04) :1537-1542